MRI detection of brain gadolinium retention in multiple sclerosis: Magnetization transfer vs. T1‐weighted imaging. Issue 2 (4th January 2023)
- Record Type:
- Journal Article
- Title:
- MRI detection of brain gadolinium retention in multiple sclerosis: Magnetization transfer vs. T1‐weighted imaging. Issue 2 (4th January 2023)
- Main Title:
- MRI detection of brain gadolinium retention in multiple sclerosis: Magnetization transfer vs. T1‐weighted imaging
- Authors:
- Cananau, Carmen
Forslin, Yngve
Bergendal, Åsa
Sjöström, Henrik
Fink, Katharina
Ouellette, Russell
Wiberg, Maria Kristoffersen
Fredrikson, Sten
Granberg, Tobias - Abstract:
- Abstract: Background and Purpose: Evidence of brain gadolinium retention has affected gadolinium‐based contrast agent usage. It is, however, unclear to what extent macrocyclic agents are retained and whether their in vivo detection may necessitate nonconventional MRI. Magnetization transfer (MT) could prove suitable to detect gadolinium‐related signal changes since dechelated gadolinium ions bind to macromolecules. Therefore, this study aimed to investigate associations of prior gadolinium administrations with MT and T1 signal abnormalities. Methods: A cohort of 23 persons with multiple sclerosis (MS) (18 females, 5 males, 57 ± 8.0 years) with multiple past gadolinium administrations (median 6, range 3‐12) and 23 age‐ and sex‐matched healthy controls underwent 1.5 Tesla MRI with MT, T1‐weighted 2‐dimensional spin echo, and T1‐weighted 3‐dimensional gradient echo. The signal intensity index was assessed by MRI in gadolinium retention predilection sites. Results: There were dose‐dependent associations of the globus pallidus signal on gradient echo ( r = .55, p < .001) and spin echo ( r = .38, p = .013) T1‐weighted imaging, but not on MT. Relative to controls, MS patients had higher signal intensity index in the dentate nucleus on T1‐weighted gradient echo (1.037 ± 0.040 vs. 1.016 ± 0.023, p = .04) with a similar trend in the globus pallidus on T1‐weighted spin echo (1.091 ± 0.034 vs. 1.076 ± 0.014, p = .06). MT detected no group differences. Conclusions: ConventionalAbstract: Background and Purpose: Evidence of brain gadolinium retention has affected gadolinium‐based contrast agent usage. It is, however, unclear to what extent macrocyclic agents are retained and whether their in vivo detection may necessitate nonconventional MRI. Magnetization transfer (MT) could prove suitable to detect gadolinium‐related signal changes since dechelated gadolinium ions bind to macromolecules. Therefore, this study aimed to investigate associations of prior gadolinium administrations with MT and T1 signal abnormalities. Methods: A cohort of 23 persons with multiple sclerosis (MS) (18 females, 5 males, 57 ± 8.0 years) with multiple past gadolinium administrations (median 6, range 3‐12) and 23 age‐ and sex‐matched healthy controls underwent 1.5 Tesla MRI with MT, T1‐weighted 2‐dimensional spin echo, and T1‐weighted 3‐dimensional gradient echo. The signal intensity index was assessed by MRI in gadolinium retention predilection sites. Results: There were dose‐dependent associations of the globus pallidus signal on gradient echo ( r = .55, p < .001) and spin echo ( r = .38, p = .013) T1‐weighted imaging, but not on MT. Relative to controls, MS patients had higher signal intensity index in the dentate nucleus on T1‐weighted gradient echo (1.037 ± 0.040 vs. 1.016 ± 0.023, p = .04) with a similar trend in the globus pallidus on T1‐weighted spin echo (1.091 ± 0.034 vs. 1.076 ± 0.014, p = .06). MT detected no group differences. Conclusions: Conventional T1‐weighted imaging provided dose‐dependent associations with gadolinium administrations in MS, while these could not be detected with 2‐dimensional MT. Future studies could explore newer MT techniques like 3D and inhomogenous MT. Notably, these associations were identified with conventional MRI even though most patients had not received gadolinium administrations in the preceding 9 years, suggestive of long‐term retention. … (more)
- Is Part Of:
- Journal of neuroimaging. Volume 33:Issue 2(2023)
- Journal:
- Journal of neuroimaging
- Issue:
- Volume 33:Issue 2(2023)
- Issue Display:
- Volume 33, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 33
- Issue:
- 2
- Issue Sort Value:
- 2023-0033-0002-0000
- Page Start:
- 247
- Page End:
- 255
- Publication Date:
- 2023-01-04
- Subjects:
- gadolinium deposition -- gadolinium retention -- gadolinium‐based contrast agents -- magnetic resonance imaging -- magnetization transfer -- multiple sclerosis
Diagnostic imaging -- Periodicals
Nervous system -- Diseases -- Diagnosis -- Periodicals
Imagerie pour le diagnostic -- Périodiques
Système nerveux -- Maladies -- Diagnostic -- Périodiques
Imagerie médicale
Neuroimagerie
Neurologie
Système nerveux
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.804754 - Journal URLs:
- http://jon.sagepub.com/ ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1552-6569 ↗
http://www.ingentaconnect.com/content/bpl/jon ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jon.13079 ↗
- Languages:
- English
- ISSNs:
- 1051-2284
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5021.548000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26321.xml